Karolinska Institute | KI

A large audience of wide-ranging stakeholders logged on to take part in BIORIMA’s final public event, held on January 19th, 2022. Organised with polished efficiency by Lisa Bregoli and Stefania Melandri, Warrant Hub, the event comprised three distinct and engaging sessions: 1. Presentation of BIORIMA Final Results 2. Nanosafety projects response to real-world needs 3. NSC-community-activity “Brainstorming of future collaboration for nanobiomaterials risk assessment”

The BIORIMA Project held its final meeting from 17th – 18th January, a large, well-attended gathering of project members from all partner organisations, the External Advisory Board, and Marcello Cacace, the Project Officer from the EC.

A safe and sustainable society and environment are the two pillars on which our future stands, and both have to be continuously supported and protected by transparent, long-sighted and science-based regulation that is shared by all actors involved. BIORIMA is contributing to these ongoing new regulatory needs by developing novel methodologies that help us to obtain the knowledge and tools to manage possible risks associated with emerging new materials, such as nano-biomaterials (NBM), when used in medical applications.